Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab

EGFR belongs to the ErbB family of receptor tyrosine kinases and is associated with worse prognosis in head and neck squamous cell carcinoma (HNSCC). Cetuximab is a monoclonal antibody to the extracellular domain of EGFR and inhibits its downstream actions via multiple mechanisms. Besides its proven...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Akshar N., Mehnert, Janice M., Kim, Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791949/
https://www.ncbi.nlm.nih.gov/pubmed/24179404
http://dx.doi.org/10.4137/CMENT.S5129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791949/
https://www.ncbi.nlm.nih.gov/pubmed/24179404
http://dx.doi.org/10.4137/CMENT.S5129

Ejemplares similares